Back to top


  /    /  LACOG 0217 – IRONMAN

Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men with Advanced Prostate Cancer

Type of Study: Epidemiological

Sponsor / Support: LACOG, Movember

Primary Objectives: Describe the practice patterns of therapeutic agents for treatment of advanced prostate cancer and overall survival and identify clinical and molecular disease subtypes that predict response to individual treatments, combinations or sequences.

Sample Size: 5.000 patients

Principal Investigator: Andre Fay

Countries LATAM: Brazil Identifier: NCT03151629

The study is open to patients participation in the following research sites:

CPO-RS - Centro de Pesquisa em Oncologia / Porto Alegre / RS / Brazil

BP - A Beneficência Portuguesa de São Paulo / São Paulo / SP / Brazil

ICTr - Instituto do Câncer e Transplante de Curitiba / Curitiba / PR / Brazil

CPO-SP - Centro de Pesquisa em Oncologia / São Paulo / SP / Brazil

ICESP - Instituto do Câncer do Estado de São Paulo / São Paulo / SP / Brazil

Hospital Tacchini / Bento Gonçalves / RS / Brazil